Related Experiment Video
Updated: Oct 5, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
The Safety of High-Dose Intranasal Fentanyl in the Pediatric Emergency Department
Insights
High-dose intranasal (IN) fentanyl, over 100 μg, is safe for pediatric patients in emergency settings. This study found no significant adverse events, supporting its use for acute pain management.
Area of Science:
- Pediatric Emergency Medicine
- Pharmacology
- Pain Management
Background:
- Intranasal (IN) fentanyl is used for pain management in pediatric emergency departments.
- Higher doses of IN fentanyl (greater than 100 μg) have not been extensively studied in pediatric populations.
Purpose of the Study:
- To determine the safety of administering IN fentanyl at doses exceeding 100 μg in pediatric patients.
- To assess adverse events associated with higher-dose IN fentanyl in a pediatric emergency setting.
Main Methods:
- Retrospective chart review of pediatric patients who received IN fentanyl.
- Data collected from an urban, tertiary care emergency department between 2011 and 2017.
- Analysis of adverse events documented through the hospital's voluntary safety reporting system.
Main Results:
- 3205 pediatric patients received over 100 μg of IN fentanyl.
- Only 3 adverse events were documented among patients receiving doses greater than 100 μg.
- No patients required naloxone or invasive respiratory support.
Conclusions:
- Doses of IN fentanyl greater than 100 μg are safe for pediatric patients.
- No clinically significant adverse outcomes were observed in this 7-year study.
- Findings support increased utilization of higher-dose IN fentanyl for acute pain in emergency and prehospital settings.
Objectives:
This study aimed to determine if the use of intranasal (IN) fentanyl in the pediatric emergency department of 2 to 5 μg/kg at doses greater than 100 μg is associated with adverse events in pediatric patients.
Methods:
We performed a retrospective chart review of patients receiving IN fentanyl at an urban, tertiary care emergency department in Memphis, TN, from January 1, 2011, to December 31, 2017. All adverse events documented through the hospital's voluntary safety reporting system involving IN fentanyl were reviewed to determine patient outcomes.
Results:
A total of 3205 patients received greater than 100 μg of IN fentanyl during the study period from 2011 to 2017. The average (SD) patient age was 13.7 (2.65) years, ranging from 5 to 18 years. The mean (SD) initial dose was 162 (30) μg ranging from 102 to 265 μg (2 doses were given greater than 200 μg in the study period). Initial average (SD) dose for weight was 2.62 (0.5) μg/kg. A total of 13 adverse events were documented, with only 3 occurring at doses greater than 100 μg. No patients required the reversal agent naloxone or invasive respiratory support.
Conclusions:
To our knowledge, this is the first study using doses greater than 100 μg of IN fentanyl in a pediatric population. Our results indicate that fentanyl can be safely administered at doses of greater than 100 μg without any clinically significant adverse outcomes observed for 7 years of use. It is our hope that this information will increase utilization of IN fentanyl for treatment of acute pain in emergency departments and in the prehospital setting.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Inhalational Anesthetics: Overview
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

